Tocilizumab for hospitalized patients with COVID-19

CMAJ. 2021 Apr 12;193(15):E521. doi: 10.1503/cmaj.210066. Epub 2021 Mar 9.

¹ Division of Infectious Diseases (Afra) and Division of Hematology (Chen), Department of Medicine; Department of Emergency Medicine (Sweet); and Centre for Health Education Scholarship (Chen), University of British Columbia; Division of Critical Care (Sweet), Department of Medicine, Vancouver General Hospital, Vancouver, BC; Division of Infectious Diseases (Afra), Department of Medicine, Fraser Health Authority, Surrey, BC kevin.afra@fraserhealth.ca.
² Division of Infectious Diseases (Afra) and Division of Hematology (Chen), Department of Medicine; Department of Emergency Medicine (Sweet); and Centre for Health Education Scholarship (Chen), University of British Columbia; Division of Critical Care (Sweet), Department of Medicine, Vancouver General Hospital, Vancouver, BC; Division of Infectious Diseases (Afra), Department of Medicine, Fraser Health Authority, Surrey, BC.

No abstract available

MeSH terms